China targets Germany's Bayer in drug price probe

Sep 13, 2013

Chinese authorities have visited an office of German pharmaceutical giant Bayer, the company said Friday, making it the latest target in a probe of foreign drug firms over high prices.

One of its offices was visited at the end of last month to investigate a potential case of "", Bayer HealthCare said in a statement to AFP.

China is mounting a sweeping probe into foreign pharmaceutical firms, accusing some of abusing their monopoly positions to boost prices unfairly.

Police are also investigating Britain's GlaxoSmithKline (GSK) over allegations employees gave bribes to sell its products.

Authorities have detained at least four GSK executives in the case, while state media has alleged the firm was responsible and not just individual employees.

Bayer said it was visited by officials of a local branch of the State Administration for Industry & Commerce, which handles market supervision and regulation.

It did not identify the location.

The company said it had strict compliance rules in place and would investigate of violations of its policy by employees.

US drugmaker Eli Lilly and France's Sanofi have both come under scrutiny after anonymous whistleblowers cited by Chinese state media claimed that employees paid .

Eli Lilly said it was investigating, while Sanofi said it was taking the claims "seriously".

Chinese authorities are investigating other industries over pricing, state media has reported, with the moves sending a chill through the foreign business community in the country.

Explore further: NBCUniversal settles with unpaid interns for $6.4M

add to favorites email to friend print save as pdf

Related Stories

China state media raises pressure on Britain's GSK

Sep 03, 2013

Chinese state media increased the pressure on British pharmaceutical giant GlaxoSmithKline (GSK) over a bribery investigation Tuesday, accusing the firm of being responsible rather than individual employees.

China shuts travel agency in GSK bribery case

Jul 19, 2013

China has shut down a travel agency which served as a conduit for bribes allegedly given by staff of British drug firm GlaxoSmithKline (GSK), the government and state media said.

China launches crackdown on drug industry

Jul 17, 2013

(AP)—China announced a crackdown Wednesday on misconduct in its drug market, stepping up pressure on the problem-prone industry while it pursues a bribery investigation of GlaxoSmithKline.

Chinese police say Glaxo employees bribed doctors

Jul 11, 2013

China's police ministry accused executives of pharmaceutical supplier GlaxoSmithKline on Thursday of conducting a large and long-running bribery campaign to persuade doctors to prescribe drugs.

Chinese police probe kickbacks by Foxconn managers

Jan 10, 2013

(AP)—Hon Hai Precision, a leading maker of iPhones and other high-tech gadgets, has said it is working with Chinese police probing allegations that its employees solicited kickbacks from suppliers.

Recommended for you

NBCUniversal settles with unpaid interns for $6.4M

1 hour ago

NBCUniversal will pay $6.4 million to settle a class action lawsuit brought by unpaid interns who worked on "Saturday Night Live" and other shows who claim they are owed wages, according to court documents.

States ascend into the cloud

1 hour ago

Seven years ago, the state of Delaware started moving computer servers out of closets and from under workers' desks to create a consolidated data center and a virtual computing climate.

Microsoft drops Nokia name from smartphones

3 hours ago

Microsoft said Friday it was dropping the Nokia name from its Lumia smartphones, rebranding following the acquisition earlier this year of the Finnish group's handset division.

Amazon's loss makes holidays a question mark

4 hours ago

Amazon's trademark smile icon is becoming more of a grimace. The world's largest online retailer reported a wider third-quarter loss than analysts expected and gave a disappointing holiday forecast.

Ericsson profit down 10 pct despite higher sales

8 hours ago

Wireless equipment maker Ericsson says its third-quarter earnings slumped 10 percent despite higher sales due to increased operating costs and negative effects from currency hedging.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

tarheelchief
not rated yet Sep 13, 2013
Since chemists from India and China went to US,Russian,EU universities,it's very hard to maintain a patent on any drug.
In the now famous HIV case the Indians produced drugs which cost less than twelve dollars a month.Similar drugs from the US cost well over ten thousand dollars a year.
If the Chinese label a German firm predatory,they can simply take their drugs and perform titrations to discover the ingredients and produce their own domestic drug industry.
The EU socialist nations can and will send out bids for the most common medications used by their citizens.I am not sure why Americans feel they cannot do the same thing.